News

2023 12 14.

CEO Shunichi Kashida delivered a keynote speech and participateed in a panel discussion at the 6th RNA-Targeted Drug Discovery & Development Summit in Boston.

From December 12th to 14th, 2023, CEO Shunichi Kashida delivered a keynote speech and participated in a panel discussion at the 6th RNA-Targeted Drug Discovery & Development Summit in Boston.

Presentation Title: Comprehensive Interactome Profiling of RNA Library vs Compound Library Identifies Selective RNA Binders

Panel Discussion Title: What Makes a ‘Good’ RNA Target? 

Click here for related Links